#MedicalDataVision

Recorded an extraordinary loss of 290 million yen due to a decline in the market value of investment securities in the Q4 consolidated accounting period of the fiscal year ending December 2025, reflected in the financial summary.

Consolidated net sales for the fiscal year ending December 2025 amounted to 6,539,159 thousand yen (10.7% YoY increase), operating income was 349,464 thousand yen, and net income attributable to owners of parent was 280,242 thousand yen. Earnings guidance for the fiscal year ending December 2026 is not provided due to delisting planned following a tender offer.

For the fiscal year ending December 2025, net sales were 6,539 million yen, up 10.7% year-over-year (YoY). Operating income stood at 349 million yen, and net income attributable to owners of parent was 280 million yen.

Nippon Life Insurance Company submitted a correction to the tender offer notification for shares of Medical Data Vision Co., Ltd. to the Kanto Local Finance Bureau Director on January 19, 2026, and made partial corrections to the tender offer commencement announcement.